Contract research organization Medpace today released the pricing for its initial public offering, looking to float 7 million shares at between $20 and $23 per share, which will bring in between $140 and $161 million. Private equity shop Cinven paid CCMP Capital Advisors $921.3 million for Cincinnati-based Medpace in 2014. The company originally registered for the […]
Clinical Research Organization (CRO)
CRO Medpace registers $150m IPO
Contract research organization Medpace last week registered for a $150 million initial public offering it plans to use to pay down some of its debt. Private equity shop Cinven paid CCMP Capital Advisors $921.3 million for Cincinnati-based Medpace in 2014. Medpace filed confidentially for the IPO back in March. Jefferies and Credit Suisse are joint book-runners for […]